A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

September 16, 2020

Study Completion Date

February 5, 2021

Conditions

Healthy VolunteersPsoriasis

Interventions

DRUG

BAY1834845

Orally administered.

OTHER

Matching Placebo

Orally administered.

DRUG

Midazolam

Part 1: Orally administered 1mg as a single dose.

Trial Locations (2)

Charité Research Organisation GmbH, Berlin

PAREXEL GmbH, Berlin